Literature DB >> 24829283

Interplay between Mdm2 and HIPK2 in the DNA damage response.

Xiao-Peng Zhang1, Feng Liu2, Wei Wang3.   

Abstract

The tumour suppressor p53 is activated to induce cell-cycle arrest or apoptosis in the DNA damage response (DDR). p53 phosphorylation at Ser46 by HIPK2 (homeodomain-interacting protein kinase 2) is a critical event in apoptosis induction. Interestingly, HIPK2 is degraded by Mdm2 (a negative regulator of p53), whereas Mdm2 is downregulated by HIPK2 through several mechanisms. Here, we develop a four-module network model for the p53 pathway to clarify the role of interplay between Mdm2 and HIPK2 in the DDR evoked by ultraviolet radiation. By numerical simulations, we reveal that Mdm2-dependent HIPK2 degradation promotes cell survival after mild DNA damage and that inhibition of HIPK2 degradation is sufficient to trigger apoptosis. In response to severe damage, p53 phosphorylation at Ser46 is promoted by the accumulation of HIPK2 due to downregulation of nuclear Mdm2 in the later phase of the response. Meanwhile, the concentration of p53 switches from moderate to high levels, contributing to apoptosis induction. We show that the presence of three mechanisms for Mdm2 downregulation, i.e. repression of mdm2 expression, inhibition of its nuclear entry and HIPK2-induced degradation, guarantees the apoptosis of irreparably damaged cells. Our results agree well with multiple experimental observations, and testable predictions are also made. This work advances our understanding of the regulation of p53 activity in the DDR and suggests that HIPK2 should be a significant target for cancer therapy.
© 2014 The Author(s) Published by the Royal Society. All rights reserved.

Entities:  

Keywords:  HIPK2 degradation; cell-fate decision; downregulation of nuclear Mdm2; p53 phosphorylation

Mesh:

Substances:

Year:  2014        PMID: 24829283      PMCID: PMC4032548          DOI: 10.1098/rsif.2014.0319

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  61 in total

Review 1.  p38(MAPK): stress responses from molecular mechanisms to therapeutics.

Authors:  Lydia R Coulthard; Danielle E White; Dominic L Jones; Michael F McDermott; Susan A Burchill
Journal:  Trends Mol Med       Date:  2009-08-06       Impact factor: 11.951

Review 2.  Transcription-independent p53 apoptosis: an alternative route to death.

Authors:  Daniel Speidel
Journal:  Trends Cell Biol       Date:  2009-10-30       Impact factor: 20.808

3.  p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation.

Authors:  M Takekawa; M Adachi; A Nakahata; I Nakayama; F Itoh; H Tsukuda; Y Taya; K Imai
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

4.  Regulation of PTEN transcription by p53.

Authors:  V Stambolic; D MacPherson; D Sas; Y Lin; B Snow; Y Jang; S Benchimol; T W Mak
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

5.  p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis.

Authors:  S Okamura; H Arakawa; T Tanaka; H Nakanishi; C C Ng; Y Taya; M Monden; Y Nakamura
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

6.  p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53.

Authors:  K Oda; H Arakawa; T Tanaka; K Matsuda; C Tanikawa; T Mori; H Nishimori; K Tamai; T Tokino; Y Nakamura; Y Taya
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

7.  Cell fate decision mediated by p53 pulses.

Authors:  Xiao-Peng Zhang; Feng Liu; Zhang Cheng; Wei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-15       Impact factor: 11.205

Review 8.  Modes of p53 regulation.

Authors:  Jan-Philipp Kruse; Wei Gu
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

Review 9.  The ups and downs of p53: understanding protein dynamics in single cells.

Authors:  Eric Batchelor; Alexander Loewer; Galit Lahav
Journal:  Nat Rev Cancer       Date:  2009-04-09       Impact factor: 60.716

10.  HIPK2 modulates p53 activity towards pro-apoptotic transcription.

Authors:  Rosa Puca; Lavinia Nardinocchi; Ada Sacchi; Gideon Rechavi; David Givol; Gabriella D'Orazi
Journal:  Mol Cancer       Date:  2009-10-14       Impact factor: 27.401

View more
  4 in total

1.  ATM and ATR Activation Through Crosstalk Between DNA Damage Response Pathways.

Authors:  Elizabeth A Fedak; Frederick R Adler; Lisa M Abegglen; Joshua D Schiffman
Journal:  Bull Math Biol       Date:  2021-03-11       Impact factor: 1.758

2.  Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin.

Authors:  Sixian Liang; Xun Peng; Xiaoli Li; Ping Yang; Linhao Xie; Yaochen Li; Caiwen Du; Guojun Zhang
Journal:  Oncotarget       Date:  2015-01-20

Review 3.  HIPK2 modification code for cell death and survival.

Authors:  Dong Wook Choi; Cheol Yong Choi
Journal:  Mol Cell Oncol       Date:  2014-10-29

Review 4.  Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies.

Authors:  Yuanyuan Feng; Lihong Zhou; Xiaoting Sun; Qi Li
Journal:  Oncotarget       Date:  2017-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.